Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Roche agrees to Ventana merger

Roche agrees to Ventana merger

24th January 2008

agreement with Ventana Medical Systems.

Approved by both boards, the acquisition of Ventana by Roche was confirmed following an offer of $89.50 (45.70 pounds) per share and an aggregate of around $3.4 billion.

Franz B Humer, chairman and chief executive officer of Roche, said the combined company will enable Ventana’s business across the globe and develop various targeted and cost-efficient medicines.

“We are delighted to welcome the employees and management team of Ventana and look forward to jointly developing novel solutions for our customers,” he added.

Ventana is focused on the tissue-based diagnostics sector and it is hoped that its offerings will help to broaden Roche’s expertise in this area in addition to its in-vitro and oncology therapies projects.

Roche currently employs some 75,000 people and its products are sold in more than 150 countries.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.